🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/06/2013 | 64,58 | 64,91 | 64,04 | 64,44 | +0,85% | 1,35% | 528.900 |
| 26/06/2013 | 62,83 | 64,55 | 62,04 | 63,90 | +2,63% | 3,99% | 941.600 |
| 25/06/2013 | 62,25 | 62,40 | 61,58 | 62,26 | +1,10% | 1,32% | 503.900 |
| 24/06/2013 | 63,01 | 63,03 | 61,23 | 61,58 | -2,78% | 2,86% | 623.600 |
| 21/06/2013 | 63,38 | 64,55 | 62,78 | 63,34 | +0,19% | 2,79% | 818.300 |
| 20/06/2013 | 64,50 | 64,85 | 62,86 | 63,22 | -2,72% | 3,09% | 458.800 |
| 19/06/2013 | 65,75 | 65,97 | 64,68 | 64,99 | -1,04% | 1,96% | 442.500 |
| 18/06/2013 | 64,80 | 65,88 | 64,41 | 65,67 | +1,41% | 2,27% | 265.600 |
| 17/06/2013 | 65,99 | 66,06 | 64,42 | 64,76 | -1,01% | 2,49% | 409.100 |
| 14/06/2013 | 65,95 | 65,95 | 64,68 | 65,42 | -0,68% | 1,93% | 270.100 |
| 13/06/2013 | 65,81 | 66,48 | 65,21 | 65,87 | -0,71% | 1,93% | 517.600 |
| 12/06/2013 | 67,52 | 67,84 | 66,24 | 66,34 | -0,72% | 2,37% | 422.400 |
| 11/06/2013 | 65,71 | 67,26 | 65,19 | 66,82 | +0,68% | 3,15% | 435.800 |
| 10/06/2013 | 67,31 | 67,46 | 65,41 | 66,37 | -0,94% | 3,05% | 329.700 |
| 07/06/2013 | 65,05 | 67,12 | 65,05 | 67,00 | +3,33% | 3,18% | 445.100 |
| 06/06/2013 | 63,48 | 64,89 | 63,25 | 64,84 | +2,11% | 2,58% | 587.400 |
| 05/06/2013 | 65,01 | 65,67 | 63,16 | 63,50 | -2,64% | 3,86% | 693.300 |
| 04/06/2013 | 66,30 | 66,73 | 64,68 | 65,22 | -1,78% | 3,09% | 509.800 |
| 03/06/2013 | 67,06 | 67,15 | 64,53 | 66,40 | -0,14% | 3,91% | 884.600 |
| 31/05/2013 | 68,97 | 69,13 | 66,46 | 66,49 | -4,07% | 3,87% | 495.500 |
| 30/05/2013 | 67,28 | 69,49 | 67,10 | 69,31 | +3,45% | 3,55% | 548.900 |
| 29/05/2013 | 66,71 | 67,75 | 66,13 | 67,00 | -0,28% | 2,43% | 538.200 |
| 28/05/2013 | 66,77 | 67,34 | 66,54 | 67,19 | +1,27% | 1,20% | 606.000 |
| 24/05/2013 | 67,58 | 67,58 | 65,25 | 66,35 | -1,86% | 3,45% | 794.100 |
| 23/05/2013 | 67,47 | 67,79 | 66,75 | 67,61 | -0,31% | 1,54% | 552.400 |
| 22/05/2013 | 68,49 | 69,65 | 67,13 | 67,82 | -0,95% | 3,68% | 581.500 |
| 21/05/2013 | 68,38 | 68,86 | 67,38 | 68,47 | +0,53% | 2,16% | 801.300 |
| 20/05/2013 | 68,67 | 69,26 | 68,06 | 68,11 | -1,53% | 1,75% | 382.300 |
| 17/05/2013 | 68,63 | 69,21 | 67,71 | 69,17 | +1,01% | 2,19% | 515.100 |
| 16/05/2013 | 67,87 | 69,17 | 67,15 | 68,48 | +0,91% | 2,98% | 920.500 |